Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23,455 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC.
Gao S, Li N, Gao S, Xue Q, Ying J, Wang S, Tao X, Zhao J, Mao Y, Wang B, Shao K, Lei W, Wang D, Lv F, Zhao L, Zhang F, Zhao Z, Su K, Tan F, Gao Y, Sun N, Wu D, Yu Y, Ling Y, Wang Z, Duan C, Tang W, Zhang L, He S, Wu N, Wang J, He J. Gao S, et al. Among authors: wu d, wu n. J Thorac Oncol. 2020 May;15(5):816-826. doi: 10.1016/j.jtho.2020.01.017. Epub 2020 Feb 6. J Thorac Oncol. 2020. PMID: 32036071 Free article. Clinical Trial.
Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody.
Wang X, Zhang B, Chen X, Mo H, Wu D, Lan B, Li Q, Xu B, Huang J. Wang X, et al. Among authors: wu d. Thorac Cancer. 2019 Jun;10(6):1395-1401. doi: 10.1111/1759-7714.13083. Epub 2019 Apr 24. Thorac Cancer. 2019. PMID: 31017739 Free PMC article. Clinical Trial.
[Awareness and Influencing Factors of Clinical Trial Among Cancer Patients in China].
Huang H, Fang Y, Fang H, Wu D, Bai Y, Wang S, Yu A, Wang H, Sun C, Fan Q, Yu Y, Yang C, Shi J, He R, Li N. Huang H, et al. Among authors: wu d. Zhongguo Fei Ai Za Zhi. 2020 Jan 20;23(1):5-14. doi: 10.3779/j.issn.1009-3419.2020.01.02. Zhongguo Fei Ai Za Zhi. 2020. PMID: 31948532 Free PMC article. Chinese.
[Acceptance and Related Causes of Clinical Trials among Cancer Patients in China].
Huang H, Fan Q, Fang H, Wu D, Wang S, Bai Y, Yu A, Wang H, Sun C, Yu Y, Fang Y, Yang S, Shi J, He R, Li N. Huang H, et al. Among authors: wu d. Zhongguo Fei Ai Za Zhi. 2020 Jan 20;23(1):41-49. doi: 10.3779/j.issn.1009-3419.2020.01.07. Zhongguo Fei Ai Za Zhi. 2020. PMID: 31948537 Free PMC article. Chinese.
Availability of anticancer biosimilars in 40 countries.
Huang HY, Wu DW, Ma F, Liu ZL, Shi JF, Chen X, Wang SH, Fang H, Bai Y, Yu Y, Fang Y, Sun C, Fan Q, Wu Y, Fan RH, Zhou CY, He BX, Dai M, Li N, Xu BH, Sun Y, He J. Huang HY, et al. Lancet Oncol. 2020 Feb;21(2):197-201. doi: 10.1016/S1470-2045(19)30860-5. Lancet Oncol. 2020. PMID: 32007192 No abstract available.
Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies.
Wang S, Chen R, Tang Y, Yu Y, Fang Y, Huang H, Wu D, Fang H, Bai Y, Sun C, Yu A, Fan Q, Gu D, Yi X, Li N. Wang S, et al. Among authors: wu d. Front Oncol. 2020 Apr 21;10:536. doi: 10.3389/fonc.2020.00536. eCollection 2020. Front Oncol. 2020. PMID: 32373528 Free PMC article.
23,455 results
You have reached the last available page of results. Please see the User Guide for more information.